Creative Innovation For Better Healthy Life

媛쒕웾떊빟 媛쒕컻

媛쒕웾떊빟(IMD : Incrementally Modified Drugs)

媛쒕웾떊빟 뿰援ы봽濡쒖젥듃 以 씪遺뒗 씠誘 援궡 궗뾽沅뚯뿉 빐 License-out씠 셿猷 맂 긽깭엯땲떎. 洹 쇅 봽濡쒖젥듃뿉 빐꽌뒗 떦궗媛 엫긽떆뿕쓣 吏꾪뻾븯怨 뭹紐⑺뿀媛沅뚯쓣 솗蹂댄븯뒗 寃껋쓣 紐⑺몴濡 븯怨 엳쑝硫, 媛쒕컻씠 셿猷뚮릺뒗 떆젏뿉 援궡,쇅 젣빟궗 젣쑕瑜 넻빐 깮궛쨌뙋留ㅽ븷 삁젙엯땲떎.

媛쒕컻셿猷 媛쒕웾떊빟 뭹紐

2008뀈 빟궗踰 媛쒖젙뿉 뵲씪 룄엯맂 "쓽빟뭹 쐞긽젣議 뙋留ㅼ뾽" 젣룄瑜 씠슜븯뿬 뾽怨 理쒖큹濡 媛쒕웾떊빟쓽 뭹紐 뿀媛瑜 痍⑤뱷뻽怨, 옄궗 뿀媛 젣뭹쓣 異붽븯怨 엳뒿땲떎.

Project Code Drug Indication Innovator Phase
GL2801
(G-SOREN®Tab.)
Artemisiae Argyi Folium
Isopropanol ext.
Gastritis Dong-A Launched
GL2602 Paroxetine 25mg Antidepressant GSK Launched
GL2504 Sibutramine maleate Anorectic Abbott Launched
GL1401 Amoxicillin + Pot. Clavulanate
dispersible tablet
Antibiotic GSK Launched